Viridian Therapeutics Reports First Quarter 2026 Financial Results and Highlights Recent Progress

Go back to Viridian Therapeutics Reports First Quarter 2026 Financial Results and Highlights Recent Progress
(NASDAQ: VRDN) Delayed: 17.63 --0 (-0%)
Previous Close $17.63    52 Week High
Open $17.63    52 Week Low
Day High $17.63    P/E N/A 
Day Low $17.63    EPS
Volume 355